entertainment -WSS

entertainment

author：focus 2025-09-30 22:05:23 - browse：71238

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

LONDON — Starting in the new year, a team of researchers in the U.K. and Denmark will begin recruiting patients for a study driven by a pressing question in medicine: How should new obesity medications be incorporated into regular practice?

Trials have demonstrated that the powerful drugs can help people shed weight in dramatic ways, but clinicians are still trying to sort out how to best use them. The medicines, after all, are pricey, come with side effects, and won’t work for everyone. And despite the excitement around these drugs, known as GLP-1s, some people might prefer or see better results with the other approaches that have long been the foundation of obesity treatment, from diet to surgery.

“These drugs clearly are very effective, and that is fantastic,” said Susan Jebb, a professor of diet and population health at the University of Oxford and one of the leaders of the project. “But we have other options for treating obesity. What we need to do now in research is understand which treatments, for which patients, at which stage of their disease.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： When prostate cancer spreads, where it goes matters

knowledge

focus

WSS

Listen: Your guide to Wegovy's blockbuster heart study

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

CDC overhauls leadership of center that led response to Covid

Solving academic medical centers' existential crisis

CDC overhauls leadership of center that led response to Covid

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

leisure time

entertainment

entertainment

At least 13 dead in Texas as scorching temps continue

Addiction experts warn against a second 'war on drugs'

Heart attack and stroke risk calculators need revising

Where are patients getting their prescriptions for GLP

At least 13 dead in Texas as scorching temps continue

It's time to retire 'poor historian' from clinicians' vocabularies

Drug repurposing or repositioning? The language matters

Military medical care influenced by rank and race, new study finds

ChatGPT in medicine: STAT answers readers' burning questions

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Wikipedia

Faced with fears of OxyContin misuse, sales reps touted its safety

After John Oliver segment, STAT readers share their opioid

Readout LOUD podcast: Live from STAT Breakthrough Summit West

An innovative path out of biotech’s “valley of death”

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Large hospital system sues Multiplan for low

knowledge

knowledge

focus

Wikipedia